TNXP logo

Tonix Pharmaceuticals Holding Corp. (TNXP)

Profile

Full Name

Tonix Pharmaceuticals Holding Corp.

Ticker

NASDAQ: TNXP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 10, 2012

Indexes

Not included

Website

https://www.tonixpharma.com

Employees

81

Key Details

Price

$27.48(-3.95%)

Market cap

$202.18M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.09M(+29.94% YoY)

Annual EPS

-$17.66K(-257710.22% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $27.48
    TNXP price is $27.48

    30-Day Relative Volume

    0.86
    TNXP 30-day relative volume is 0.86

    Price Performance

    Price Today change

    -3.95%
    TNXP price is down -3.95% today

    Price YTD change

    -16.73%
    TNXP price is down -16.73% since January 1st

    Price 1-year change

    +71.75%
    TNXP price is up +71.75% year-on-year

    Price 3-year change

    -99.84%
    TNXP price is down -99.84% over the past 3 years

    Price Range

    Price All-time high

    $19.20B
    TNXP price is currently -100.00% below its historical high of $19.20 billion

    Price 3-year low

    $6.76
    TNXP price is currently +306.51% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $202.18M
    TNXP market capitalization is $202.18 million

    Market cap 3-year change

    +434.29%
    TNXP market capitalization is up +434.29% over the past 3 years

    Market cap All-time high

    $640.00M
    TNXP market capitalization is currently -68.41% below its historical high of $640.00 million

    Market cap sector rank

    50.5%
    TNXP market capitalization is higher than 50.5% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +475.37%
    TNXP shares outstanding is up +475.37% year-on-year

    Shares Outstanding 3-Year Change

    +334318.18%
    TNXP shares outstanding is up +334318.18% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.93
    TNXP beta is 0.93

    200-day SMA

    $28.28
    TNXP price is currently -2.83% below its 200-day simple moving average

    50-day SMA

    $39.83
    TNXP price is currently -31.01% below its 50-day simple moving average

    RSI

    40.56
    TNXP 14-day relative strength index is 40.56

    Volume

    0.86
    TNXP 30-day relative volume is 0.86

    ATR

    $3.70
    TNXP average true range is $3.70

    10-day Historical Volatility

    111.40%
    TNXP 10-day historical volatility is 111.40%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $10.09M
    TNXP annual revenue is $10.09 million

    Revenue Analysts estimate

    $8.70M
    TNXP annual revenue is currently +16.02% higher than the consensus analysts' forecast

    Revenue 1-year change

    +29.94%
    TNXP annual revenue is up +29.94% year-on-year

    Revenue Sector rank

    48.34%
    TNXP annual revenue is higher than 48.34% of companies in Healthcare sector

    EPS

    EPS

    -$17.66K
    TNXP annual earnings per share is -$17.66 thousand

    EPS Analysts estimate

    -$10.30
    TNXP annual earnings per share is currently >+9900.00% higher than the consensus analysts' forecast

    EPS 1-year change

    -257710.22%
    TNXP annual earnings per share is down -257710.22% year-on-year

    EPS Sector rank

    0.17%
    TNXP annual earnings per share is higher than 0.17% of companies in Healthcare sector

    Profit

    Gross profit

    -$1.09M
    TNXP annual gross profit is -$1.09 million

    Gross margin

    -10.82%
    TNXP annual gross profit margin is -10.82%

    Operating profit

    -$77.74M
    TNXP annual operating income is -$77.74 million

    Operating margin

    -770.20%
    TNXP annual operating profit margin is -770.20%

    Net income

    -$130.04M
    TNXP annual net profit is -$130.04 million

    Net margin

    -1288.25%
    TNXP annual net profit margin is -1288.25%

    Expenses

    Total expenses

    $140.13M
    TNXP annual total expenses is $140.13 million

    Operating expenses

    $76.65M
    TNXP annual total operating expenses is $76.65 million

    Cost of goods sold

    $11.19M
    TNXP annual cost of goods sold is $11.19 million

    Selling, general & administrative expenses

    $0.00
    TNXP annual SGA is $0.00

    Depreciation and amortization

    $3.42M
    TNXP annual depreciation & amortization is $3.42 million

    Interest expense

    $0.00
    TNXP annual interest expense is $0.00

    Income tax

    $0.00
    TNXP annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$77.74M
    TNXP annual earnings before interest & taxes is -$77.74 million

    EBITDA

    -$74.32M
    TNXP annual EBITDA is -$74.32 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $162.89M
    TNXP annual total assets is $162.89 million

    Non current assets

    $43.89M
    TNXP annual long term assets is $43.89 million

    Current assets

    $119.00M
    TNXP annual total current assets is $119.00 million

    Cash and cash equivalents

    $98.78M
    TNXP annual cash & cash equivalents is $98.78 million

    Accounts receivable

    $4.56M
    TNXP annual accounts receivable is $4.56 million

    Inventory

    $8.41M
    TNXP annual inventory is $8.41 million

    Liabilities

    Total liabilities

    $23.33M
    TNXP annual total liabilities is $23.33 million

    Long term liabilities

    $5.03M
    TNXP annual total long term liabilities is $5.03 million

    Current liabilities

    $18.31M
    TNXP annual total current liabilities is $18.31 million

    Accounts payable

    $4.55M
    TNXP annual accounts payable is $4.55 million

    Debt

    Total debt

    $8.12M
    TNXP annual total debt is $8.12 million

    Total debt 1-year change

    -17.26%
    TNXP annual total debt is down -17.26% year-on-year

    Long term debt

    $5.03M
    TNXP annual long term debt is $5.03 million

    Short term debt

    $3.09M
    TNXP annual short term debt is $3.09 million

    Equity & Capital

    Shareholders equity

    $139.56M
    TNXP annual stockholders equity is $139.56 million

    Book value

    $139.56M
    TNXP annual book value is $139.56 million

    Retained earnings

    -$730.69M
    TNXP annual retained earnings is -$730.69 million

    Working capital

    $100.69M
    TNXP annual working capital is $100.69 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$60.92M
    TNXP annual cash flow from operations is -$60.92 million

    Cash from operations 1-year change

    +40.27%
    TNXP annual cash flow from operations is up +40.27% year-on-year

    Cash from investing

    -$120.00K
    TNXP annual cash flow from investing activities is -$120.00 thousand

    Cash from investing 1-year change

    +99.59%
    TNXP annual cash flow from investing activities is up +99.59% year-on-year

    Cash from financing

    $134.87M
    TNXP annual cash flow from financing activities is $134.87 million

    Cash from financing 1-year change

    +269.34%
    TNXP annual cash flow from financing activities is up +269.34% year-on-year

    CAPEX

    CAPEX

    $120.00K
    TNXP annual capital expenditures is $120.00 thousand

    CAPEX 1-year change

    -98.48%
    TNXP annual capital expenditures is down -98.48% year-on-year

    Free Cash Flow

    Free cash flow

    -$61.05M
    TNXP annual free cash flow is -$61.05 million

    Free cash flow 1-year change

    +44.45%
    TNXP annual free cash flow is up +44.45% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -10.82%
    TNXP annual gross profit margin is -10.82%

    Operating margin

    -770.20%
    TNXP annual operating profit margin is -770.20%

    Net margin

    -1288.25%
    TNXP annual net profit margin is -1288.25%

    ROA & ROE

    ROA

    -81.95%
    TNXP annual return on assets is -81.95%

    ROE

    -106.12%
    TNXP annual return on equity is -106.12%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TNXP price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TNXP price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.20
    TNXP price to book ratio is 1.20

    PB ratio Sector rank

    38.3%
    TNXP price to book ratio is higher than 38.3% of companies in Healthcare sector

    PS Ratio

    PS ratio

    20.57
    TNXP price to sales ratio is 20.57

    PS ratio Sector rank

    80.57%
    TNXP price to sales ratio is higher than 80.57% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $77.34M
    TNXP enterprise value is $77.34 million

    Enterprise value Sector rank

    43.7%
    TNXP enterprise value is higher than 43.7% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.96
    TNXP EV/EBITDA is -0.96

    EV/EBITDA Sector rank

    47.76%
    TNXP EV/EBITDA is higher than 47.76% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.50
    TNXP annual current ratio is 6.50

    Quick ratio

    6.04
    TNXP annual quick ratio is 6.04

    Leverage

    Debt to equity

    0.06
    TNXP annual debt to equity ratio is 0.06

    Interest coverage ratio

    -
    TNXP annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    TNXP piotroski f-score is 4

    Altman Z-Score

    -1.85
    TNXP altman z-score is -1.85

    Analyst ratings

    Recent major analysts updates

    Mar 20, 25 Noble Capital Markets
    Outperform
    Jul 22, 24 Alliance Global Partners
    Buy
    Feb 28, 24 Dawson James
    Buy
    Aug 1, 23 Alliance Global Partners
    Buy
    Jun 2, 23 Alliance Global Partners
    Buy
    Jan 12, 23 Alliance Global Partners
    Buy
    Apr 18, 22 Noble Capital Markets
    Outperform
    Aug 31, 21 Alliance Global Partners
    Buy
    Aug 11, 21 Alliance Global Partners
    Buy
    Feb 25, 21 Alliance Global Partners
    Buy

    Institutional Ownership

    Screeners with TNXP included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    • What is the ticker symbol for Tonix Pharmaceuticals Holding Corp.?
    • Does Tonix Pharmaceuticals Holding Corp. pay dividends?
    • What sector is Tonix Pharmaceuticals Holding Corp. in?
    • What industry is Tonix Pharmaceuticals Holding Corp. in?
    • What country is Tonix Pharmaceuticals Holding Corp. based in?
    • When did Tonix Pharmaceuticals Holding Corp. go public?
    • Is Tonix Pharmaceuticals Holding Corp. in the S&P 500?
    • Is Tonix Pharmaceuticals Holding Corp. in the NASDAQ 100?
    • Is Tonix Pharmaceuticals Holding Corp. in the Dow Jones?
    • When was Tonix Pharmaceuticals Holding Corp.'s last earnings report?
    • When does Tonix Pharmaceuticals Holding Corp. report earnings?

    What is the ticker symbol for Tonix Pharmaceuticals Holding Corp.?

    The ticker symbol for Tonix Pharmaceuticals Holding Corp. is NASDAQ:TNXP

    Does Tonix Pharmaceuticals Holding Corp. pay dividends?

    No, Tonix Pharmaceuticals Holding Corp. does not pay dividends

    What sector is Tonix Pharmaceuticals Holding Corp. in?

    Tonix Pharmaceuticals Holding Corp. is in the Healthcare sector

    What industry is Tonix Pharmaceuticals Holding Corp. in?

    Tonix Pharmaceuticals Holding Corp. is in the Biotechnology industry

    What country is Tonix Pharmaceuticals Holding Corp. based in?

    Tonix Pharmaceuticals Holding Corp. is headquartered in United States

    When did Tonix Pharmaceuticals Holding Corp. go public?

    Tonix Pharmaceuticals Holding Corp.'s initial public offering (IPO) was on May 10, 2012

    Is Tonix Pharmaceuticals Holding Corp. in the S&P 500?

    No, Tonix Pharmaceuticals Holding Corp. is not included in the S&P 500 index

    Is Tonix Pharmaceuticals Holding Corp. in the NASDAQ 100?

    No, Tonix Pharmaceuticals Holding Corp. is not included in the NASDAQ 100 index

    Is Tonix Pharmaceuticals Holding Corp. in the Dow Jones?

    No, Tonix Pharmaceuticals Holding Corp. is not included in the Dow Jones index

    When was Tonix Pharmaceuticals Holding Corp.'s last earnings report?

    Tonix Pharmaceuticals Holding Corp.'s most recent earnings report was on August 11, 2025

    When does Tonix Pharmaceuticals Holding Corp. report earnings?

    The next expected earnings date for Tonix Pharmaceuticals Holding Corp. is November 11, 2025
    On this page